16/05/2025 | Qiming Venture Partners V, L.P. | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | 16/05/2025 | QM32 Limited | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | 16/05/2025 | Qiming GP V, L.P. | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | 16/05/2025 | Qiming Corporate GP V, Ltd. | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | 08/05/2025 | Suzhou Qicheng Investment Management Partnership (Limited Partnership) | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | 08/05/2025 | 于佳 | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | 08/05/2025 | Suzhou Qiming Ronghe Venture Capital Partnership (Limited Partnership) | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | 08/05/2025 | Shanghai Qichang Investment Consulting Co., Ltd. | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | 08/05/2025 | 胡旭波 | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | 22/04/2025 | LAV Kecheng Hong Kong Limited | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | 22/04/2025 | LAV Corporate VI GP Opportunities, Ltd. | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | 22/04/2025 | LAV Fund VI Opportunities, L.P. | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | 22/04/2025 | LAV GP VI Opportunities, L.P. | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | 22/04/2025 | Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) | 1101(L) | | | 24,776,804(L) | 11.90 | 22/04/2025 | 陈飞 | 1101(L) | | | 24,776,804(L) | 11.90 | 22/04/2025 | 施毅 | 1101(L) | +3,000,000(L) | | 20,091,680(L) | 45.98 | 07/03/2025 | OrbiMed Advisors V Limited | 1101(L) | +4,589,900(L) | HKD 4.990(L) | 19,651,800(L) | 11.61 | 07/03/2025 | OrbiMed Asia GP V, L.P. | 1101(L) | +4,589,900(L) | HKD 4.990(L) | 19,651,800(L) | 11.61 | 07/03/2025 | OrbiMed Asia Partners V, L.P. | 1101(L) | +4,589,900(L) | HKD 4.990(L) | 19,651,800(L) | 11.61 | 27/12/2024 | 劉秀 | 1106(L) | | | 36,000(L) | 0.02 | 27/12/2024 | 于非 | 1106(L) | | | 36,000(L) | 0.02 | 27/12/2024 | 施永輝 | 1106(L) | | | 626,900(L) | 0.37 | 14/10/2024 | OrbiMed Advisors V Limited | 1101(L) | +4,500(L) | HKD 4.160(L) | 13,541,500(L) | 8.00 | 14/10/2024 | OrbiMed Asia Partners V, L.P. | 1101(L) | +4,500(L) | HKD 4.160(L) | 13,541,500(L) | 8.00 | 14/10/2024 | OrbiMed Asia GP V, L.P. | 1101(L) | +4,500(L) | HKD 4.160(L) | 13,541,500(L) | 8.00 | 29/07/2024 | OrbiMed Asia Partners V, L.P. | 1001(L) | +12,055,200(L) | HKD 3.710(L) | 12,055,200(L) | 7.12 | 29/07/2024 | OrbiMed Asia GP V, L.P. | 1001(L) | +12,055,200(L) | HKD 3.710(L) | 12,055,200(L) | 7.12 | 29/07/2024 | OrbiMed Advisors V Limited | 1001(L) | +12,055,200(L) | HKD 3.710(L) | 12,055,200(L) | 7.12 | 23/05/2024 | LAV Evergreen (Hong Kong) Co., Limited | 1113(L) | 8,545,840(L) | | 8,545,840(L) | 5.05 | 23/05/2024 | Qiming Corporate GP V, Ltd. | 1113(L) | | | 11,925,181(L) | 7.05 | 23/05/2024 | 施永辉 | 1711(L) | | | 590,900(L) | 0.35 | 23/05/2024 | Lilly Asia Ventures Fund GP, L.P. | 1113(L) | 8,545,840(L) | | 8,545,840(L) | 5.05 | 23/05/2024 | QM32 Limited | 1113(L) | | | 11,925,181(L) | 7.05 | 23/05/2024 | Lilly Asia Ventures Fund II, L.P. | 1113(L) | 8,545,840(L) | | 8,545,840(L) | 5.05 | 23/05/2024 | LAV Corporate GP, Ltd. | 1113(L) | 8,545,840(L) | | 8,545,840(L) | 5.05 | 23/05/2024 | 鄭攀 | 1711(L) | | | 41,690,719(L) | 24.63 | 23/05/2024 | Qiming Venture Partners V, L.P. | 1113(L) | | | 11,925,181(L) | 7.05 | 23/05/2024 | Qiming GP V, L.P. | 1113(L) | | | 11,925,181(L) | 7.05 | 28/03/2024 | CD Capital GP Ltd | 1001(L) | +3,000,000(L) | | 10,026,231(L) | 5.76 | 28/03/2024 | CD Capital Healthcare FUND V, L.P. | 1001(L) | +3,000,000(L) | | 10,026,231(L) | 5.76 | | 1 2 |
|